Search Results
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
August, 2024
August 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jul
AACR
Jan 14, 2024, 09:53 |
Career
Karen Knudsen: It is a privilege to have her join the American Cancer Society Board of Directors!
Karen Knudsen, CEO of the American Cancer Society and American Cancer Society Cancer Action Network,…
Jan 10, 2024, 18:21 |
Blog
Top Precision Oncology articles of 2023 by Vivek Subbiah
Vivek Subbiah shared on X/Twitter: "By popular demand delighted to share the 'Top Precision Oncology…
Jan 6, 2024, 11:46 |
Blog
Urvi Shah: Jasmin Hundal and I summarize the results of the DIANA-5 trial
Urvi Shah, Oncologist and Researcher on Myeloma Service at the Memorial Sloan Kettering Cancer Centre,…
Jan 5, 2024, 17:36 |
Insight
Talha Badar: What is the right duration of Venetoclax with HMA for AML?
Talha Badar, Assistant Professor of Oncology at Mayo Clinic Comprehensive Cancer Center, shared on X/Twitter:…
Jan 3, 2024, 12:32 |
Blog
Mark Lawler: A true leader in cancer and great friend of Ireland
Mark Lawler, Professor of Digital Health and Chair in Translational Cancer Genomics, shared a post by Kimryn…
Dec 31, 2023, 20:07 |
Blog
Katsuaki Maehara: Patritumab Deruxtecan (HER3-DXd) clinical trial transition
Katsuaki Maehara, Director of Medical Education Colleagues, recently shared a post by EGFR Resisters on X/Twitter,…
Dec 24, 2023, 18:34 |
Insight
Norbert Kraut: A must-read Precision Oncology: 2023 in Review
Norbert Kraut, Global Head of Cancer Research, Boehringer Ingelheim, shared on X/Twitter: "2023 has been…
Dec 23, 2023, 16:26 |
Blog
Oliver Bogler: Explore the role of policy and government in shaping the future of cancer research
Oliver Bogler, Director of the Center for Cancer Training at the National Cancer Institute (NCI),…
Dec 23, 2023, 04:00 |
Insight
Vivek Subbiah: Such a delight to share our non-human primate publication as a pre-cursor to our First-in-human phase 1 trial
Vivek Subbiah shared on X/Twitter: ''Such a delight to share our non-human primate publication on First-in-cynomolgus…
Dec 23, 2023, 03:25 |
Drugs
Katsuaki Maehara: Therapeutic development of 4th generation TKIs is active for acquired resistance to osimelnitinib for C797
Katsuaki Maehara, Director of Medical Education Colleagues, recently shared the following on X/Twitter: "Therapeutic development…
60
61
62
63
64
All:
677
Posts:
611 - 620
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024
Uniting Forces: Leveraging Cancer Research to Revolutionize Tuberculosis Treatment
Lance Armstrong and Testicular Cancer: Story, Symptoms, Treatment
Honoring Jeff Weber, a giant in the field of oncology
Douglas Flora: The Great Wave off Kanagawa captures my feelings on certain days
Facebook
RSS Feed
Twitter
Linkedin
Youtube